Wednesday February 10 2010 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
  • A-Z


BioPortfolio's Pharmaceutical Approved Drug News and targeted searches

NEWS - A-Z of 4000 Approved Drugs by Tradename - click alphabet for listing:

Aa-Al | Am-Az | B | Ca-Ci | Cj-Cz | D | E | F | G | H | I - J | K - L | M | N | O | Pa-Pf | Pg-Pz | Qa-Sa | Sb-Sz | Ta-Th | Ti-Tz | U-V | W-Z

PROFILES (targeted searches) - A-Z of 4000 Approved Drugs by Active Ingredient - click alphabet for listing:

Aa-Al | Am-Az | B | Ca-Ci | Cj-Cz | D | E | F | G | H | I - J | K - L | M | N | O | Pa-Pf | Pg-Pz | Qa-Sa | Sb-Sz | Ta-Th | Ti-Tz | U-V | W-Z
 

Search BioNews

      --- Advanced searching ---

 

Latest Pharmaceutical Drug Approval News:

Review and approval of oncology and hematology drugs at FDA from 2005 to 2007
Genetic Engineering News:  similar ...
Regis Technologies Passes FDA Pre-Approval Inspection for Acorda Therapeutics Approved Multiple Sclerosis D
Genetic Engineering News:  similar ...
Review and approval of oncology and hematology drugs at FDA from 2005 to 2007
Genetic Engineering News:  similar ...
Elan Drug Technologies Welcomes the NDA Approval of MS Drug AMPYRA (Dalfampridine) Extended Release Tablets
Pharma Live:  similar ...
Review and approval of oncology and hematology drugs at FDA from 2005 to 2007
EurekAlert!:  similar ...
Review and approval of oncology and hematology drugs at FDA from 2005 to 2007
Genetic Engineering News:  similar ...
Elan Drug Technologies Welcomes The NDA Approval Of MS Drug AMPYRA (Dalfampridine) Extended Release Tablets
Medical News Today:  similar ...
Elan Drug Technologies Welcomes the NDA Approval of MS Drug AMPYRA (Dalfampridine) Extended Release Tab
Genetic Engineering News:  similar ...
Elan Drug Technologies Welcomes the NDA Approval of MS Drug AMPYRA (Dalfampridine) Extended Release Tablets
SmartBrief:  similar ...
Elan Drug Technologies Welcomes the NDA Approval of MS Drug AMPYRA„ (Dalfampridine) Extended Release T
PharmiWeb:  similar ...
Elan Drug Technologies Welcomes the NDA Approval of MS Drug AMPYRA„ (Dalfampridine) Extended Release T
Business Wire UK:  similar ...
Elan Corporation PLC UK Regulatory Announcement: Elan Drug Technologies Welcomes the NDA Approval of MS Drug A
Business Wire UK:  similar ...
Elan Corporation PLC : Elan Drug Technologies Welc...
Investegate:  similar ...
Elan Drug Technologies Welcomes the NDA Approval of MS Drug AMPYRA (Dalfampridine) Extended Release Tablets
Yahoo! Canada:  similar ...
Elan Drug Technologies Welcomes the NDA Approval of MS Drug AMPYRA(TM) (Dalfampridine) Extended Release Tablet
Elan:  similar ...
Elan Drug Technologies Welcomes the NDA Approval of MS Drug AMPYRA(TM) (Dalfampridine) Extended Release Tablets
Street Insider:  similar ...
Elan Drug Technologies Welcomes the NDA Approval of MS Drug AMPYRA(TM) (Dalfampridine) Extended Release Tablets
Street Insider:  similar ...
Elan Drug Technologies Welcomes the NDA Approval of MS Drug AMPYRA(TM) (Dalfampridine) Extended Release Tablets
Street Insider:  similar ...
Elan Drug Technologies Welcomes the NDA Approval of MS Drug AMPYRA (Dalfampridine) Extended Release Tablets
FinanzNachrichten.de:  similar ...
Elan Drug Technologies Welcomes the NDA Approval of MS Drug AMPYRA (Dalfampridine) Extended Release Tablets
FinanzNachrichten.de:  similar ...

 


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright © 1997-2009 - BioPortfolio Limited.